Therapy and clinical trials.

dc.contributor.author	Chongthammakun, Vasutakarn
dc.contributor.author	Krasuski, Richard A
dc.coverage.spatial	England
dc.date.accessioned	2015-12-03T15:34:11Z
dc.date.issued	2014-10
dc.identifier	http://www.ncbi.nlm.nih.gov/pubmed/25186204
dc.identifier	00041433-201410000-00016
dc.identifier.eissn	1473-6535
dc.identifier.uri	https://hdl.handle.net/10161/10987
dc.language	eng
dc.publisher	Ovid Technologies (Wolters Kluwer Health)
dc.relation.ispartof	Curr Opin Lipidol
dc.relation.isversionof	10.1097/MOL.0000000000000116
dc.subject	Cardiovascular Diseases
dc.subject	Clinical Trials as Topic
dc.subject	Diabetes Mellitus
dc.subject	Guidelines as Topic
dc.subject	Humans
dc.subject	Hydroxymethylglutaryl-CoA Reductase Inhibitors
dc.title	Therapy and clinical trials.
dc.type	Journal article
duke.contributor.orcid	Krasuski, Richard A\|0000-0003-3150-5215
pubs.author-url	http://www.ncbi.nlm.nih.gov/pubmed/25186204
pubs.begin-page	410
pubs.end-page	411
pubs.issue	5
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Duke
pubs.organisational-group	Medicine
pubs.organisational-group	Medicine, Cardiology
pubs.organisational-group	School of Medicine
pubs.publication-status	Published
pubs.volume	25

Files

Now showing 1 - 1 of 1